Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
3,262
Total Claims
$426K
Drug Cost
348
Beneficiaries
$1,224
Cost/Patient
Risk Score Breakdown 11/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-81%
Opioid rate vs peers
0.5% vs 2.5% avg
+9%
Cost per patient vs peers
$1,224 vs $1,128 avg
+72%
Brand preference vs peers
14.5% vs 8.4% avg
Opioid Prescribing
0.5%
Opioid Rate
15
Opioid Claims
$121
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 467 claims · $321K
Generic: 2,764 claims · $103K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 26 | $35K |
| Semaglutide | 34 | $34K |
| Semaglutide | 28 | $31K |
| Apixaban | 25 | $30K |
| Dulaglutide | 19 | $29K |
| Insulin Glargine/Lixisenatide | 16 | $13K |
| Rivaroxaban | 18 | $13K |
| Fluticasone/Umeclidin/Vilanter | 19 | $13K |
| Evolocumab | 15 | $12K |
| Diclofenac Sodium | 87 | $7,840 |
| Duloxetine Hcl | 66 | $6,178 |
| Celecoxib | 48 | $5,460 |
| Atorvastatin Calcium | 221 | $5,040 |
| Fluticasone Propion/Salmeterol | 11 | $4,365 |
| Gabapentin | 127 | $3,949 |
Prescribing Profile
Patient Profile
73
Avg Age
79%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About